Retatrutide Dosage Chart To make it easier to see how the dosage progresses, heres a simplified chart: This is just a guide
Requires split draw
When you track those conditions, you can respond with more understanding and less shame
Key weight loss results at 48 weeks by group: Response rates at 48 weeks (12 mg dose): 100% achieved greater than or equal to 5% weight loss 93% achieved greater than or equal to 10% weight loss 83% achieved greater than or equal to 15% weight loss The cardiometabolic improvements were also significant, with reductions in blood pressure, triglycerides, LDL cholesterol, HbA1c, fasting glucose, and fasting insulin across all dose groups
No studies have directly compared the effects of retatrutide and other GLP-1 medications, but vomiting may have been slightly more common in retatrutide trials than in trials for currently available options
Additionally, sodium-glucose cotransporter 2 (SGLT2) inhibitors, known for their glycemic and cardiovascular benefits, when combined with incretin-based therapies, have demonstrated additive improvements in weight loss, glycemic control, and liver function markers
